Myriad Genetics reported $-3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Becton, Dickinson and Co. USD 1.11B 357M Sep/2026
Bio-Rad Laboratories USD 72.6M 38.5M Jun/2026
Bruker USD 83.5M 13.9M Sep/2026
Danaher USD 1.25B 118M Sep/2026
Illumina USD 305M 45M Sep/2026
J&J USD 6.47B 1B Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Myriad Genetics USD -3M 20.3M Dec/2025
OraSure Technologies USD -13.59M 2.13M Dec/2025
Pacific Biosciences Of California USD -53.19M 35.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Quidel USD 12.1M 27.4M Sep/2026
Repligen USD 24.31M 3.18M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Standard Biotools USD -7.83M 1.59M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Veracyte USD 18.02M 5.94M Sep/2026
Waters USD -86M 234M Jun/2026